During this post-American Society of Clinical Oncology (ASCO) Annual Meeting wrap-up webinar, ZS experts highlighted some of the most exciting findings presented at the conference. New clinical research unveiled at ASCO 2022 has the potential to significantly alter the treatment of some cancers. Hosted by OBR and sponsored by ZS, our panel included insights from Dr. Debra Patt, MD and Dr. Lee Schwartzberg, MD. Key themes of the discussion include:

  • Advances in breast cancer treatments in specific patient subpopulations
  • CAR-T use and opportunity in solid tumors
  • The era of liquid biopsy
  • Non-small cell lung cancer updates: Immune-oncology and beyond


  • Preeti Premraj, MBBS, decision analytics manager, ZS
  • Pavankumar Anne, MBA, associate principal, ZS
  • Dr. Debra Patt, MD, PhD, MBA, executive vice president,  Texas Oncology
  • Dr. Lee Schwartzberg, MD, chief, medical oncology and hematology, professor of clinical medicine, Renown Institute for Cancer, University of Nevada